Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Vasculitis
Description
Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. MeSH
Hierarchy View
Subtype Terms (14)
Arteritis
2 drugs (1 approved, 1 experimental)
Behcet Syndrome
38 drugs (32 approved, 6 experimental)
IgA Vasculitis
16 drugs (12 approved, 4 experimental)
Mucocutaneous Lymph Node Syndrome
14 approved drugs
Phlebitis
7 drugs (5 approved, 2 experimental)
Retinal Vasculitis
4 approved drugs
Systemic Vasculitis
7 drugs (6 approved, 1 experimental)
Thromboangiitis Obliterans
5 drugs (2 approved, 3 experimental)
Vasculitis, Central Nervous System
9 drugs (6 approved, 3 experimental)
Vasculitis, Leukocytoclastic, Cutaneous
10 drugs (9 approved, 1 experimental)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (4)
Organization Involved with Phase 4 Indications (31)
Dezhou People's Hospital,Shandong
Dongying People's Hospital, Shandong
Jining City Dermatology Hospital Prevention and Treatment
Laiwu City Dermatology Hospital Prevention and Treatment
Linyi City Dermatology Hospital Prevention and Treatment
Organization Involved with Phase 2 Indications (25)
National Cancer Institute (NCI)
National Center for Advancing Translational Science (NCATS)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization Involved with Other Experimental Indications (5)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
